eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
December 20 2024
The British Journal of Sports Medicine recently published a systematic review that analyzed the effects of postpartum exercise on maternal postpartum ...
Research has demonstrated that low serum vitamin D can cause myalgia, myositis, myopathy, and myonecrosis. Statin-induced myalgia is a major and common cause of statin intolerance. In a study of 146 adults with myalgia related statin intolerance found to have low (<32 ng/mL) serum vitamin D, researchers prospectively assessed whether vitamin D supplementation to normalize serum vitamin D would allow successful re-challenge therapy with statins. Median serum vitamin D levels at entry in the 24 month study was 22-23 ng/mL, and rose at 6, 12, and 24 months to 53-55 ng/mL, normalizing in 95% of patients after 24 months following vitamin D therapy. On the 6, 12 and 24 month follow-up on re-challenged patients on statins and vitamin D, 88%, 91% and 95% of the previously statin-intolerant patients, respectively, were free of myalgia, myositis, myopathy, and/or myonecrosis! Before beginning the study, all the patients had experience myalgia, myositis, myopathy, or myonecrosis on statins (predominantly simvastatin, atorvastatin or lovastatin). This current study supports the findings of three previous studies associating statin related myalgias with low serum vitamin D status. By providing supplemental vitamin D to statin-intolerant patients with low serum vitamin D at entry, 88% were subsequently able to tolerate re-challenge with stains with excellent tolerability, and the LDLC lowering to targeted levels. Researchers concluded that statin intolerance because of myalgia, myositis, myopathy, or myonecrosis in vitamin D deficient patients can, in most cases (88%-95%)be safely resolved by vitamin D supplementation!
Khayznikov M, et al. Statin Intolerance Because of Myalgia, Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D supplementation. N Am J Med Sci. 2015 Mar; 7(3): 86-93.
Submit this form and you'll receive our latest news and updates.
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment